COVID-19 Rapid Response Innovation Project


A test to measure the prognosis of COVID-19 patients entering hospital

The challenge

As doctors try to deal with COVID-19, they need to understand each patient’s prognosis and what kind of treatment that patient can handle. Without more information about these parameters, doctors cannot make the best decisions about managing their patients’ treatment.

The solution

The ProCop project aims to develop and validate a new blood-based score for COVID-19 to help determine: 1) the severity of a patient’s condition and their prognosis; 2) the patient’s likelihood of developing a drug-induced-liver-injury due to COVID-19 medication. This innovative and simple-to-use severity score comprises a blood-sample followed by an automated algorithmic computation. The algorithm takes into account the patient’s age, gender and the results of five routine assays to test for proteins and enzymes in the blood. The resulting prognosis will be available within two hours.

Expected impact

The ProCop Severity Score will give doctors information they need to tailor the treatment and management of each patient. Hospitals can use the predictions to assess the resources they will need to treat their patients in the next 14 days.

All Partners

EIT Health Partner

  • Assistance Publique – Hôpitaux de Paris

External partner

  • BioPredictive
Patrice CACOUB
| | APHP
| | BioPredictive